| 臺大學術典藏 |
2020-03-07T06:56:23Z |
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker in Predicting Pathological Response to Neoadjuvant Chemoradiation
|
Hsu F.-M.;Cheng J.C.-H.;Yih-Leong Chang;Lee J.-M.;Koong A.C.;Chuang E.Y.; Hsu F.-M.; Cheng J.C.-H.; YIH-LEONG CHANG; Lee J.-M.; Koong A.C.; Chuang E.Y. |
| 臺大學術典藏 |
2020-03-31T03:59:25Z |
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker in Predicting Pathological Response to Neoadjuvant Chemoradiation
|
Chuang E.Y.; Koong A.C.; JANG-MING LEE; Chang Y.-L.; Hsu F.-M.; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-05-25T02:45:35Z |
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker in Predicting Pathological Response to Neoadjuvant Chemoradiation
|
Feng-Ming Hsu; Cheng J.C.-H; Chang Y.-L; Lee J.-M; Koong A.C; Chuang E.Y. |
| 臺大學術典藏 |
2020-03-06T05:26:12Z |
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker in Predicting Pathological Response to Neoadjuvant Chemoradiation
|
Hsu F.-M.; Cheng J.C.-H.; YIH-LEONG CHANG; Lee J.-M.; Koong A.C.; Chuang E.Y. |
| 臺大學術典藏 |
2018-09-10T15:18:40Z |
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker in Predicting Pathological Response to Neoadjuvant Chemoradiation
|
陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維; Hsu, Feng-Ming; Liu, Chen-Hua; YIH-LEONG CHANG; Cheng, Jason Chia-Hsien; Huang, Chung-Feng; ERIC YAO-YU CHUANG; Chang, Yih-Leong; JANG-MING LEE; Liu, Chun-Jen; Dai, Chia-Yen; Lee, Jang-Ming; Huang, Jee-Fu; Koong, Albert C.; Lin, Jou-Wei; Chuang, Eric Y.; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; Hsu, Feng-Ming;Cheng, Jason Chia-Hsien;Chang, Yih-Leong;Lee, Jang-Ming;Koong, Albert C.;Chuang, Eric Y.; Hsu, F.-M. and Cheng, J.C.-H. and Chang, Y.-L. and Lee, J.-M. and Koong, A.C. and Chuang, E.Y.; 張逸良;成佳憲;李章銘;許峰銘; 成佳憲 |
| 臺大學術典藏 |
2021-08-21T23:58:35Z |
Circulating p-cresyl sulfate, non-hepatic alkaline phosphatase and risk of bone fracture events in chronic kidney disease-mineral bone disease
|
Chang, Jia Feng; Hsieh, Chih Yu; Liou, Jian Chiun; Lu, Kuo Cheng; Zheng, Cai Mei; Wu, Mai Szu; SHU-WEI CHANG; Wang, Ting Ming; Wu, Chang Chin |
| 臺大學術典藏 |
2022-03-22T08:25:25Z |
Circulating p-cresyl sulfate, non-hepatic alkaline phosphatase and risk of bone fracture events in chronic kidney disease-mineral bone disease
|
Chang J.-F;Hsieh C.-Y;Liou J.-C;Lu K.-C;Zheng C.-M;Wu M.-S;Chang S.-W;Wang T.-M;Wu C.-C.; Chang J.-F; Hsieh C.-Y; Liou J.-C; Lu K.-C; Zheng C.-M; Wu M.-S; Chang S.-W; Wang T.-M; Wu C.-C.; SHU-WEI CHANG |
| 臺大學術典藏 |
2022-03-22T08:28:10Z |
Circulating p-cresyl sulfate, non-hepatic alkaline phosphatase and risk of bone fracture events in chronic kidney disease-mineral bone disease
|
Chang J.-F;Hsieh C.-Y;Liou J.-C;Lu K.-C;Zheng C.-M;Wu M.-S;Chang S.-W;Wang T.-M;Wu C.-C.; Chang J.-F; Hsieh C.-Y; Liou J.-C; Lu K.-C; Zheng C.-M; Wu M.-S; Chang S.-W; Wang T.-M; Wu C.-C.; SHU-WEI CHANG |
| 臺大學術典藏 |
2022-03-22T08:28:10Z |
Circulating p-cresyl sulfate, non-hepatic alkaline phosphatase and risk of bone fracture events in chronic kidney disease-mineral bone disease
|
Chang J.-F;Hsieh C.-Y;Liou J.-C;Lu K.-C;Zheng C.-M;Wu M.-S;Chang S.-W;Wang T.-M;Wu C.-C.; Chang J.-F; Hsieh C.-Y; Liou J.-C; Lu K.-C; Zheng C.-M; Wu M.-S; Chang S.-W; Wang T.-M; Wu C.-C.; SHU-WEI CHANG |
| 臺大學術典藏 |
2021-06-24T06:46:44Z |
Circulating pituitary hormones in primary aldosteronism.
|
Hsieh B.S.; Chang C.C.; Chen F.W.; WAN-YU CHEN; Yen T.S. |
| 國立成功大學 |
2020-06 |
Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand
|
Chiu;Chen-Tzu;Wang;Pei-Wen;Asare-Werehene;Meshach;Tsang;Benjamin, K.;Shieh;Dar-Bin |
| 國立成功大學 |
2007-02 |
Circulating polymerase chain reaction chips utilizing multiple-membrane activation
|
Wang, Chih-Hao; Chen, Yi-Yu; Liao, Chia-Sheng; Hsieh, Tsung-Min; Luo, Ching-Hsing; Wu, Jiunn-Jong; Lee, Huei-Huang; Lee, Gwo-Bin |
| 國家衛生研究院 |
2016-10-27 |
Circulating progenitor cells affect thrombosis of dialysis arteriovenous fistulas
|
Chen, TY;Lin, TT;Hsieh, MY;Lin, L;Yang, CW;Chuang, SY;Huang, PH;Wu, CC |
| 臺大學術典藏 |
2021-08-23T01:06:32Z |
Circulating Progenitor Cells Affect Thrombosis of Dialysis Arteriovenous Fistulas
|
Chen T.-Y.; Lin T.-T.; Hsieh M.-Y.; Lin L.; CHUNG WEI YANG; Chuang S.-Y.; Huang P.-H.; Wu C.-C. |
| 臺大學術典藏 |
2022-02-23T02:19:48Z |
Circulating Progenitor Cells Affect Thrombosis of Dialysis Arteriovenous Fistulas
|
Chen T.-Y.; Lin T.-T.; Hsieh M.-Y.; Lin L.; Yang C.-W.; Chuang S.-Y.; Huang P.-H.; CHIH-CHENG WU |
| 臺大學術典藏 |
2022-01-06T08:31:11Z |
Circulating Progenitor Cells Affect Thrombosis of Dialysis Arteriovenous Fistulas
|
Wu, Chih Cheng |
| 臺大學術典藏 |
2022-09-13T08:19:09Z |
Circulating Progenitor Cells Affect Thrombosis of Dialysis Arteriovenous Fistulas
|
Chen T.-Y.; Lin T.-T.; Hsieh M.-Y.; Lin L.; Yang C.-W.; Chuang S.-Y.; Huang P.-H.; CHIH-CHENG WU |
| 國立臺灣大學 |
2014 |
Circulating Programmed Death-1 as a Marker for Sustained High Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma
|
Cheng, Hsiang-Yun; Kang, Pei-Jen; Chuang, Ya-Hui; Wang, Ya-Hui; Jan, Meng-Chin; Wu, Chih-Feng; Lin, Chih-Lin; Liu, Chun-Jen; Liaw, Yun-Fan; Lin, Shi-Ming; Chen, Pei-Jer; Lee, Shou-Dong; Yu, Ming-Whei; 于明暉; 莊雅惠; 劉俊人; 陳培哲 |
| 臺大學術典藏 |
2018-09-10T14:57:14Z |
Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870
|
Yu, Ming-Whei; Yu, Ming-Whei; Lee, Shou-Dong; Chen, Pei-Jer; Lee, Shou-Dong; Chen, Pei-Jer; Chen, Pei-Jer; Lin, Shi-Ming; Lin, Shi-Ming; Liaw, Yun-Fan; Liaw, Yun-Fan; Liu, Chun-Jen; Liu, Chun-Jen; Cheng, Hsiang-Yun;Kang, Pei-Jen;Chuang, Ya-Hui;Wang, Ya-Hui;Jan, Meng-Chin;Wu, Chih-Feng;Lin, Chih-Lin;Liu, Chun-Jen;Liaw, Yun-Fan;Lin, Shi-Ming;Chen, Pei-Jer;Lee, Shou-Dong;Yu, Ming-Whei; MING-WHEI YU; Cheng, Hsiang-Yun; CHUN-JEN LIU; Kang, Pei-Jen; PEI-JER CHEN; Chuang, Ya-Hui; Chuang, Ya-Hui; Wang, Ya-Hui; YA-HUI CHUANG; Jan, Meng-Chin; Jan, Meng-Chin; Wu, Chih-Feng; Lin, Chih-Lin; Liu, Chun-Jen |
| 臺大學術典藏 |
2020-07-01T06:54:59Z |
Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870
|
Cheng H.-Y.;Kang P.-J.;Ya-Hui Chuang;Wang Y.-H.;Jan M.-C.;Wu C.-F.;Lin C.-L.;Liu C.-J.;Liaw Y.-F.;Lin S.-M.;Chen P.-J.;Lee S.-D.;Yu M.-W.; Cheng H.-Y.; Kang P.-J.; YA-HUI CHUANG; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Chen P.-J.; Lee S.-D.; Yu M.-W. |
| 臺大學術典藏 |
2021-07-03T03:34:05Z |
Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870
|
Cheng H.-Y.; Kang P.-J.; Chuang Y.-H.; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN; Lee S.-D.; Yu M.-W. |
| 臺大學術典藏 |
2022-01-24T09:31:38Z |
Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870
|
Cheng H.-Y.; Kang P.-J.; Chuang Y.-H.; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; CHUN-JEN LIU; Liaw Y.-F.; Lin S.-M.; Chen P.-J.; Lee S.-D.; Yu M.-W. |
| 臺大學術典藏 |
2022-04-29T08:09:50Z |
Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870
|
Cheng H.-Y.; Kang P.-J.; Chuang Y.-H.; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Chen P.-J.; Lee S.-D.; MING-WHEI YU |
| 臺大學術典藏 |
2021-05-27T08:09:46Z |
Circulating proteoglycan endocan mediates EGFR-driven progression of non-small cell lung cancer
|
Yang Y.-C.;Pan K.-F.;Lee W.-J.;Chang J.-H.;Tan P.;Gu C.-C.;Chang W.-M.;Yang S.-F.;Hsiao M.;Kuo-Tai Hua;Chien M.-H.; Yang Y.-C.; Pan K.-F.; Lee W.-J.; Chang J.-H.; Tan P.; Gu C.-C.; Chang W.-M.; Yang S.-F.; Hsiao M.; KUO-TAI HUA; Chien M.-H. |
| 中山醫學大學 |
2020 |
Circulating Proteoglycan Endocan Mediates EGFR-Driven Progression of Non-Small Cell Lung Cancer
|
Yang, YC; Pan, KF; Lee, WJ; Chang, JH; Tan, P; Gu, CC; Chang, WM; Yang, SF; Hsiao, M; Hua, KT; Chien, MH |
| 義守大學 |
2013-10 |
Circulating secreted frizzled-related protein 5 (Sfrp5) and wingless-type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus
|
Yung-Chuan Lu;Chao-Ping Wang;Chia-Chang Hsu;Cheng-An Chiu;Teng-Hung Yu;Wei-Chin Hung;Li-Fen Lu;Fu-Mei Chung;I-Ting Tsai;Hsien-Chang Lin;Yau-Jiunn Lee |
| 義守大學 |
2018-10 |
Circulating secreted frizzled-related protein 5 and chronic kidney disease in patients with acute ST-segment elevation myocardial infarction
|
Chao-Ping Wang;Teng-Hung Yu;Cheng-Ching Wu;Wei-Chin Hung;Chia-Chang Hsu;I-Ting Tsai;Wei-Hua Tang;Fu-Mei Chung;Jer-Yiing Houng;Yau-Jiunn Lee;Yung-Chuan Lu |
| 中國文化大學 |
2022-10 |
Circulating serum amyloid A levels but not SAA1 variants predict long-term outcomes of angiographically confirmed coronary artery disease
|
Wu, Semon |
| 國立臺灣大學 |
2002 |
Circulating Soluble Fas Ligand Correlates with Disease Activity in Graves ' Hyperthyroidism
|
王治元; 鍾文彬; 張天鈞; 蔡元奮; WANG, CHIH-YUAN; ZHONG, WEN-BIN; CHANG, TIEN-CHUN; TSAI, YUAN-FEEN |
| 臺大學術典藏 |
2018-09-10T04:05:53Z |
Circulating soluble fas ligand correlates with disease activity in Graves' hyperthyroidism
|
Wang, C.-Y. and Zhong, W.-B. and Chang, T.-C. and Tsai, Y.-F.; CHIH-YUAN WANG; TIEN-CHUN CHANG |
| 臺大學術典藏 |
2020-06-01T09:06:43Z |
Circulating soluble fas ligand correlates with disease activity in Graves' hyperthyroidism
|
Chih-Yuan Wang;Zhong W.-B.;Chang T.-C.;Tsai Y.-F.; CHIH-YUAN WANG; Zhong W.-B.; Chang T.-C.; Tsai Y.-F. |
| 臺大學術典藏 |
2020-06-03T07:24:05Z |
Circulating soluble fas ligand correlates with disease activity in Graves' hyperthyroidism
|
Tsai Y.-F.;TIEN-CHUN CHANG;Zhong W.-B.;Wang C.-Y.; Wang C.-Y.; Zhong W.-B.; TIEN-CHUN CHANG; Tsai Y.-F. |
| 臺北醫學大學 |
2002 |
Circulating soluble Fas ligand correlates with disease activity in Graves' hyperthyroidism.
|
鍾文彬; Wang CY; Zhong WB; Chang TC; Tsai YF; ; |
| 國立臺灣大學 |
2002 |
Circulating soluble Fas ligand correlates with disease activity in Graves’ hyperthyroidism.
|
蔡元奮 |
| 國家衛生研究院 |
2019-05-15 |
Circulating sphingosine-1-phosphate as a prognostic biomarker for community-acquired pneumonia
|
Hsu, SC;Chang, JH;Hsu, YP;Bai, KJ;Huang, SK;Hsu, CW |
| 國立成功大學 |
2022 |
Circulating SSEA-1+ stem cell-mediated tissue repair in allergic airway inflammation
|
Chiu, Chiu C.-J.;Liao, C.-C.;Hsu, Y.-H.;Chiang, B.-L. |
| 國立臺灣大學 |
2015 |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Hung, Chi-Sheng; Chou, Chia-Hung; Wu, Xue-Ming; Chang, Yi-Yao; Wu, Vin-Cent; Chen, Ying-Hsien; Chang, Yuan-Shian; Tsai, Yao-Chou; Su, Ming-Jai; Ho, Yi-Lwun; Chen, Ming-Fong; Wu, Kwan-Dun; Lin, Yen-Hung; 林彥宏; 洪啟盛; 陳明豐; 吳允升; 吳寬墩; 陳盈憲; 蘇銘嘉; 何奕倫 |
| 臺大學術典藏 |
2020-09-28T07:04:44Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Lin Y.-H.; Wu K.-D.; Chen M.-F.; Ho Y.-L.; Su M.-J.; Tsai Y.-C.; Chang Y.-S.; Chen Y.-H.; Wu X.-M.; Chang Y.-Y.; Hung C.-S.; Chou C.-H. |
| 臺大學術典藏 |
2020-12-01T07:10:07Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Hung C.-S.;Chou C.-H.;Wu X.-M.;Chang Y.-Y.;Wu V.-C.;Chen Y.-H.;Chang Y.-S.;Tsai Y.-C.;Su M.-J.;Yi-Lwun Ho;Chen M.-F.;Wu K.-D.;Lin Y.-H.; Hung C.-S.; Chou C.-H.; Wu X.-M.; Chang Y.-Y.; Wu V.-C.; Chen Y.-H.; Chang Y.-S.; Tsai Y.-C.; Su M.-J.; YI-LWUN HO; Chen M.-F.; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2020-12-23T02:57:33Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Lin Y.-H.; Wu K.-D.; Hung C.-S.;Chou C.-H.;Wu X.-M.;Chang Y.-Y.;Vin-Cent Wu;Chen Y.-H.;Chang Y.-S.;Tsai Y.-C.;Su M.-J.;Ho Y.-L.;Chen M.-F.;Wu K.-D.;Lin Y.-H.; Hung C.-S.; Chou C.-H.; Wu X.-M.; Chang Y.-Y.; VIN-CENT WU; Chen Y.-H.; Chang Y.-S.; Tsai Y.-C.; Su M.-J.; Ho Y.-L.; Chen M.-F. |
| 臺大學術典藏 |
2020-12-18T05:20:51Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Hung C.-S.; Chou C.-H.; Wu X.-M.; Chang Y.-Y.; Wu V.-C.; Chen Y.-H.; Chang Y.-S.; Tsai Y.-C.; Su M.-J.; Ho Y.-L.; Chen M.-F.; Wu K.-D.; YEN-HUNG LIN |
| 臺大學術典藏 |
2021-05-31T06:17:57Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Hung C.-S.; Chou C.-H.; Wu X.-M.; Chang Y.-Y.; Wu V.-C.; Chen Y.-H.; Chang Y.-S.; Tsai Y.-C.; MING-JAI SU; Ho Y.-L.; Chen M.-F.; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2020-12-28T09:31:21Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Lin Y.-H.; Wu K.-D.; Chen M.-F.; Ho Y.-L.; Hung C.-S.; Chou C.-H.; Wu X.-M.; Chang Y.-Y.; Wu V.-C.; YING-HSIEN CHEN; Chang Y.-S.; Tsai Y.-C.; Su M.-J. |
| 臺大學術典藏 |
2021-11-30T04:54:03Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Hung C.-S.; Chou C.-H.; Wu X.-M.; Chang Y.-Y.; VIN-CENT WU; Chen Y.-H.; Chang Y.-S.; Tsai Y.-C.; Su M.-J.; Ho Y.-L.; Chen M.-F.; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2018-09-10T15:21:32Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction.
|
Lin, Yen-Hung;Wu, Kwan-Dun;Chen, Ming-Fong;Ho, Yi-Lwun;Su, Ming-Jai;Tsai, Yao-Chou;Chang, Yuan-Shian;Chen, Ying-Hsien;Wu, Vin-Cent;Chang, Yi-Yao;Wu, Xue-Ming;Chou, Chia-Hung;Hung, Chi-Sheng;何奕倫;蘇銘嘉;陳盈憲;吳寬墩;吳允升;陳明豐;洪啟盛;林彥宏;VIN-CENT WU;YEN-HUNG LIN;YI-LWUN HO; Hung, Chi-Sheng; VIN-CENT WU; YEN-HUNG LIN; Chou, Chia-Hung; YI-LWUN HO; Wu, Xue-Ming; Chang, Yi-Yao; Wu, Vin-Cent; Chen, Ying-Hsien; Chang, Yuan-Shian; Tsai, Yao-Chou; Su, Ming-Jai; Ho, Yi-Lwun; Chen, Ming-Fong; Wu, Kwan-Dun; Lin, Yen-Hung; 林彥宏; 洪啟盛; 陳明豐; 吳允升; 吳寬墩; 陳盈憲; 蘇銘嘉; 何奕倫 |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chou R.-H.;Huang C.-Y.;Huang P.-H.;Leu H.-B.;Yin W.-H.;Chau-Chung Wu;Lin S.-J.;Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; CHAU-CHUNG WU; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:18Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Yin W.-H.; Wu C.-C.; Lin S.-J.; Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B. |
| 臺大學術典藏 |
2021-03-18T08:54:08Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; Wu C.-C.; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2022-02-07T07:48:57Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
Lin P.-H.; Wang M.-Y.; Lo C.; Tsai L.-W.; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; SUNG-HSIN KUO; Huang C.-S. |
| 臺大學術典藏 |
2021-12-09T06:35:42Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
Lin P.-H.; Wang M.-Y.; Lo C.; LI-WEI TSAI; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
